A detailed history of Moran Wealth Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Moran Wealth Management, LLC holds 2,592 shares of BIIB stock, worth $382,034. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,592
Previous 2,637 1.71%
Holding current value
$382,034
Previous $611,000 17.84%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$189.07 - $236.8 $8,508 - $10,656
-45 Reduced 1.71%
2,592 $502,000
Q2 2024

Aug 13, 2024

BUY
$190.52 - $236.72 $71,826 - $89,243
377 Added 16.68%
2,637 $611,000
Q1 2024

May 15, 2024

BUY
$212.02 - $267.71 $33,499 - $42,298
158 Added 7.52%
2,260 $487,000
Q4 2023

Feb 07, 2024

BUY
$222.59 - $267.94 $467,884 - $563,209
2,102 New
2,102 $543,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.2B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Moran Wealth Management, LLC Portfolio

Follow Moran Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moran Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moran Wealth Management, LLC with notifications on news.